Share ownership Bristol-Myers Squibb Company

BMY

US1101221083

Pharmaceuticals

Market Closed - Nyse Other stock markets 04:00:02 2026-02-13 pm EST			5-day change	1st Jan Change
60.74 ^USD	+1.47%		-0.05%	+12.61%

Feb. 11	Tranche Update on Bristol-Myers Squibb Company's Equity Buyback Plan announced on October 27, 2016.	CI
Feb. 09	AstraZeneca's Evinova Enters Clinical Development AI Partnership Deal	MT

Share class: Bristol-Myers Squibb Company

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	2,923,312,023	1,985,940,000 ( 67.93 %)	894,000,000 ( 30.58 %)	67.93 %

Major shareholders: Bristol-Myers Squibb Company

Name	Equities	%	Valuation
Vanguard Fiduciary Trust Co. 9.762 %	198,727,768	9.762 %	10 940 M $
BlackRock Advisors LLC 6.175 %	125,715,547	6.175 %	6 921 M $
STATE STREET CORPORATION 4.813 %	97,980,438	4.813 %	5 394 M $
JPMorgan Investment Management, Inc. 3.705 %	75,425,467	3.705 %	4 152 M $
Charles Schwab Investment Management, Inc. 3.503 %	71,322,392	3.503 %	3 926 M $
Geode Capital Management LLC 2.586 %	52,638,346	2.586 %	2 898 M $
BlackRock Life Ltd. 2.205 %	44,894,968	2.205 %	2 471 M $
Norges Bank (13F) 1.773 %	36,100,698	1.773 %	1 987 M $
Ameriprise Financial Services LLC 1.595 %	32,473,834	1.595 %	1 788 M $
Eaton Vance Management 1.393 %	28,348,754	1.393 %	1 561 M $
░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░

Name	Equities	%	Valuation
VSM Wealth Advisory LLC 0.6974 %	20	0.6974 %	18 554 $

Name	Equities	%	Valuation
State Street Global Advisors Europe Ltd. 0.0183 %	372,956	0.0183 %	20 M $

Name	Equities	%	Valuation
Transcend Capital Advisors LLC -	109,175	-	8 843 $
Davenport & Co. LLC -	83,970	-	6 802 $
Maven Investment Partners US Ltd. (US) -	67,856	-	5 496 $
Purkiss Capital Advisors LLC -	26,450	-	2 142 $
Watts Gwilliam & Co. LLC -	20,000	-	1 620 $
FIFTH THIRD BANCORP -	20,000	-	1 620 $
Private Advisor Group LLC -	15,000	-	1 215 $
Two Sigma Securities LLC -	12,741	-	1 032 $
Northwestern Mutual Wealth Management Co. -	341	-	28 $
Rothschild Investment LLC -	166	-	13 $
░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░

Breakdown by shareholder type

Institutional	66.27%
Other	8.98%
State Street Corp.	4.81%
Schweizerische Nationalbank	0.27%
Sumitomo Mitsui Trust Group, Inc.	0.26%
Skandinaviska Enskilda Banken AB	0.2%
Swedbank AB	0.15%
Governments	0.14%
SEI Investments Co.	0.13%
Manulife Financial Corp.	0.07%
Danske Bank A/S	0.06%
The Bank of Nova Scotia	0.04%
Individuals	0.04%
Banco Bilbao Vizcaya Argentaria SA	0.03%
Old Republic International Corp.	0.03%
Fifth Third Bancorp	0.03%
Zurich Insurance Group AG	0.02%
ING Groep NV	0.02%
Peapack-Gladstone Financial Corp.	0.02%
Hancock Whitney Corp.	0.02%
AlTi Global, Inc.	0.01%
Silvercrest Asset Management Group, Inc.	0.01%
Phoenix Financial Ltd.	0.01%
Banque Cantonale Vaudoise	0.01%
First Horizon Corp. (Tennessee)	0.01%
Regions Financial Corp.	0.01%
The Allstate Corp.	0.01%
Cullen/Frost Bankers, Inc.	0.01%
Kinsale Capital Group, Inc.	0.01%
Unknown	18.32%

Based on 1000 largest holdings

Geographical origin of shareholders

United States	60.26%
United Kingdom	9.81%
Norway	2.05%
Canada	2.05%
France	1.23%
Australia	1.19%
Sweden	0.73%
Japan	0.7%
Switzerland	0.66%
Netherlands	0.55%
Germany	0.43%
South Korea	0.35%
Ireland	0.22%
Belgium	0.2%
Denmark	0.18%
Austria	0.16%
Luxembourg	0.16%
New Zealand	0.13%
Hong Kong	0.12%
Italy	0.11%
Spain	0.09%
Finland	0.07%
Taiwan	0.05%
Individuals	0.04%
Czech Republic	0.03%
Singapore	0.03%
United Arab Emirates	0.01%
Cayman Islands	0.01%
India	0.01%
Israel	0.01%
Mexico	0.01%
China	0.01%
South Africa	0.01%
Liechtenstein	0.01%

Based on 1000 largest holdings

Bristol-Myers Squibb Company est spécialisé dans le développement, la fabrication et la commercialisation de produits pharmaceutiques. Les produits sont destinés au traitement des cancers, des maladies cardio-vasculaires, de l'hépatite, des maladies immunitaires et des désordres psychiatriques. The United States account for 69.1% of net sales.

Employees

32,500

Sector

Pharmaceuticals

Calendar

Apr. 30 - Q1 2026 Earnings Release

More about the company